Regentis Biomaterials Ltd. Cash Equivalents, at Carrying Value
Regentis Biomaterials Ltd. (RGNT) had Cash Equivalents, at Carrying Value of $7.38 million as of 2025-12-31, per its 20-F/A filed 2026-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-02-27
- 2025-12-31: Cash Equivalents, at Carrying Value $7.38M.
- 2024-12-31: Cash Equivalents, at Carrying Value $229.00K.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $7.38M 20-F/A · filed 2026-02-27 |
| 2024-12-31 | $229.00K 20-F/A · filed 2026-02-27 |